Efficacy of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorCentre Hospitalier St Anne

About this trial

Efficacy of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Double-Blind Controlled Trial

Eligibility criteria

Qualifiers

Adult patient aged 18 to 60 years inclusive

Patient diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD), combined or predominantly inattentive presentation, previously established by a healthcare professional

Patients must be registered in the active caseload of the Adult Neurodevelopmental Disorders Unit (STNDA)

Stable psychotropic medication regimen for at least four weeks prior to inclusion, in terms of both molecule and dosage, particularly for methylphenidate, or no current psychotropic treatment. Medication must remain unchanged throughout study participation, unless medically justified changes are required

Disqualifiers

Diagnosis of Autism Spectrum Disorder (ASD)

Diagnosis of personality disorder (Cluster A, B, C, or other), according to DSM-5-TR

Diagnosis of schizophrenia spectrum disorder or other psychotic disorders according to DSM-5-TR

Diagnosis of bipolar disorder with manic episode or history of manic episodes according to DSM-5-TR

Trial design

Treatments tested in this trial

  • Transcranial direct current stimulation (tDCS)

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators